USA Food and Drug Administration Qualifies the FACE-Q Aesthetics Module as a MDDT

On April 26, 2022, the U.S. Food and Drug Administration (FDA) announced the qualification of the FACE-Q Aesthetics Module for facial aesthetics studies through the agency’s Medical Device Development Tool (MDDT) Program. Qualification of the FACE-Q Aesthetics module included the following 11 scales:

Qualified Self-Perceived Facial Appearance Scales:

1. Satisfaction with Cheeks

2. Satisfaction with Facial Appearance

3. Lines Between Eyebrows

4. Appraisal of Lines: Nasolabial Folds

5. Satisfaction with Lips

6. Satisfaction with Skin 

Qualified Health-Related Quality of Life Scales:

1. Aging Appraisal

2. Early Life Impact of Treatment

3. Satisfaction with Outcome

4. Psychological Function

5. Social Function  

More information can be found here: